🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8760
-0.4340 (-33.13%)
At close: Nov 20, 2026, 4:00 PM EST
0.8620
-0.0140 (-1.60%)
After-hours: Nov 20, 2026, 7:40 PM EST

PMV Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-88.53-77.74-58.71-68.96-73.32-57.85
Depreciation & Amortization
0.110.131.141.260.320.31
Loss (Gain) From Sale of Assets
0.020.040.06---
Loss (Gain) From Sale of Investments
-1.71-2.77-5.37-5.39-0.630.55
Stock-Based Compensation
5.95.928.8712.3810.25.34
Other Operating Activities
15.05-0.074.31-0.370.240.96
Change in Accounts Payable
-1.76-3.423.340.24-0.390.19
Change in Other Net Operating Assets
1.294.34-4.935.19-0.183.93
Operating Cash Flow
-69.63-73.58-51.28-55.66-63.76-46.57
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.02-0.03-0.66-0.96-7.98-1.35
Sale of Property, Plant & Equipment
00.030.25---
Investment in Securities
5.8670.1753.76-49.586.62-142.24
Investing Cash Flow
5.8470.1753.35-50.55-1.37-143.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
51.30.510.3135.580.962.02
Other Financing Activities
-3.86-----
Financing Cash Flow
47.440.510.3135.580.962.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
00.01-0.040.03--
Net Cash Flow
-16.34-2.892.35-70.59-64.17-188.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-69.64-73.61-51.94-56.62-71.74-47.92
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.23-1.40-1.01-1.18-1.57-1.06
Levered Free Cash Flow
-42.75-46.94-40.92-32.94-48.97-27.51
Unlevered Free Cash Flow
-42.75-46.94-40.92-32.94-48.97-27.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
-----0.02
Change in Working Capital
-0.470.91-1.595.43-0.574.12
SEC Filings: 10-K · 10-Q